Opinion|Videos|November 17, 2026

The Evolving Pharmacist Role in HIV Care and Long-Acting Therapy

Rather than converging on a single regimen, HIV drug development is expanding choice, and the late-stage pipeline points toward weekly, twice-yearly, and potentially yearly dosing.

"The Evolving Pharmacist Role in HIV Care and Long-Acting Therapy" explores how pharmacy practice is shifting as HIV becomes a manageable chronic condition.

Dr. Durham says the pharmacist's role is ever evolving, though pharmacists have always been integral to HIV care. He describes HIV's progression from an acute, fatal illness to a controllable chronic disease, much like hypertension or diabetes. Pharmacists still help control the virus, but they now also manage the concomitant disease states that accompany aging with HIV. He highlights growing pharmacist involvement in PrEP and PEP, including pharmacist-run PrEP clinics. Looking ahead, he expects pharmacists to take on procurement, payment, and even administration of long-acting injectables. Patients might receive injections at a pharmacy rather than traveling to a clinic.

Dr. Madison emphasizes that pharmacists are the most accessible health care professionals. She notes that the average patient lives within five miles of a community pharmacy, which helps remove barriers to care. Dr. Burkhart adds that the reimbursement network is highly complex. Pharmacists must know whether a product will be billed under the medical benefit, the prescription benefit, or through a buy-and-bill model. He believes pharmacists need dedicated training to navigate these pathways.

Dr. Nguyen describes a pilot program in Texas that trains pharmacies to administer long-acting injectables. The current protocol covers long-acting cabotegravir for prevention and cabotegravir/rilpivirine for treatment. Pharmacists can offer patients an alternative when they cannot reach the clinic, including after-hours options for people with restrictive work schedules.

Dr. Madison closes the topic by urging pharmacists to look beyond viral suppression. People with HIV can now expect a life expectancy similar to that of people without HIV. Pharmacists can support sexual and reproductive health, hypertension, diabetes, and hormone therapy. The goal is holistic care that addresses the whole patient rather than the virus alone.

In "Switching Virologically Suppressed HIV Patients: Signals, Switch Rates, and Resistance," Dr. Burkhart opens the next discussion on recognizing when a suppressed patient may still benefit from a switch.

Funding supported by Gilead. Content independently developed by Pharmacy Times.


Related to this article